CNO agonist: High-potency ligands for DREADD imaging and activation in rodents and monkeys
Compound E: Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients
CNO agonist: High-potency ligands for DREADD imaging and activation in rodents and monkeys
Compound E: Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients